Bioactivity-directed fractionation of the n-butanol extract of fresh fruits of Randia siamensis led to the isolation of 4 new ginsenosides: pseudoginsenosides-RT 2 , -RT 3 , -RT 4 and -RT 5 , together with 7 known compounds. Tyramine was found to be responsible for the hypertensive activity, whereas pseudoginsenosides-RT 1 and -RP 1 were responsible for the hypotensive activity. The structures were determined by spectroscopic and chemical methods.
Randia siamensis belongs to the subfamily Gardennieae of the family Rubiaceae. It can be found in all parts of Thailand and Burma, especially in humid regions. R. siamensis is known by various local names in Thailand: Khat khao, Khet khao, Khat khao naam and Khat khao thuea. All parts of this plant have been used in Thai traditional medicine. For example, the fruits have been used for inducing abortion, the leaves are claimed to control blood pressure, the root is used for antipyretic and antiscurvy activities, and the flowers have been used to stop nosebleeds [1] . In previous studies, the fruits of this plant have been shown to contain D-mannitol, β-sitosterol, campesterol, ursolic acid, mesembryanthemoidigenic acid, pseudoginsenoside-RT 1 , pseudoginsenoside-RP 1 , and siamenoside [2, 3] .
In pharmacological studies, Reanmongkol et al. found that R. siamensis extract produces antinociceptive actions similar to those of the peripherally-acting analgesic drug aspirin. The authors also found that pseudoginsenoside-RP 1 might partly contribute to the anti-nociceptive action of the extract [4] . Studies on rats showed that pseudoginsenoside RT 1 decreased blood pressure, increased heart rate and increased spontaneous contractility of the uterus [5] .
A preliminary study on the effects of the n-butanol extract from fresh fruits of R. siamensis on the cardiovascular system showed that it produced hypertensive and positive chronotropic effects in anesthetized rats [5] . It also produced hypotensive activity if the animals were pre-treated with phentolamine, a non-specific adrenergic receptor antagonist, which indicated that at least three different activities were found in the n-butanol extract from fresh fruits of R. siamensis. Thus it was of interest to isolate the pure compounds and find out whether the various activities were due to either one constituent or different compounds. The knowledge obtained would be useful for confirming the traditional uses, as well as providing an opportunity to develop a cardiovascular drug.
Compounds 1-6 and 9 were easily identified from chemical and spectroscopic data and by comparison Saponin 8 gave a pseudomolecular ion at m/z 941 [M-H]in the ESIMS analysis, which corresponded to a molecular formula of C 47 H 74 O 19 . The 1 H NMR spectrum showed the presence of three signals at δ 4.40, 4.09 and 4.41, correlated with those of three carbons at δ 103, 104 and 105 by an HMQC experiment and was diagnostic for the presence of three sugars. The GC-MS analysis after acid hydolysis of 8 afforded glucose, arabinose and glucuronic acid. All proton and carbon signals of these sugars were assigned after analysis of the 2D NMR spectra. Acid hydrolysis gave mesembryanthemoidigenic acid. The HMBC spectral data allowed the interglycosidic linkage arabinopyranosyl-(1→2)-glucuronic acid to be established. The correlations observed in the HMBC spectrum between δ 4.41 and δ 90.0 indicated the presence of a glucuronic acid in position C-3, while the glucose correlations between δ 4.09 and δ 80.0 indicated the presence of a glucose in position C-29. The anomeric configuration of the different sugars was deduced as β using the coupling constants. The presence of a methyl ester of glucuronic acid was ascertained from the HSQC and HMBC spectra. The 1 H NMR spectrum showed the methyl signal at δ 3.68 (s, 3H) attached to a carbon at δ 53.0 (HSQC spectrum). The HMBC analysis indicated the correlations between this signal and the carbonyl group at δ 169.9 of the glucuronic acid. On the basis of 2D NMR spectroscopic data, all proton and carbon signals of these sugars were assigned. The HMBC spectrum showed the sugar sequence to be glucopyranosyl-(3→1)-glucuronic acid. The attachment of the sugar chain at carbon C-3 was ascertained from the HMBC spectrum. In this spectrum the correlations between the anomeric protons at Intravenous injection of tyramine (0.01-1.00 mg/kg) caused dose-dependent increases in MAP and heart rate in anesthetized rats (Figures 1a and 1b) . These effects lasted for 10 min at the highest dose of 1.0 mg/kg. Low doses of pseudoginsenoside-RT 1 (1.0-3.0 mg/kg) produced a minute and transient decrease in MAP with no changes in heart rate (Figures 1c and  1d) . At doses of 10 and 30 mg/kg, however, substantial decreases in MAP with no changes in heart rate were obtained and this effect lasted over 60 min (Figure 2a ). In the case of pseudoginsenoside-RP 1 , at small doses of 1.0-3.0 mg/kg, a similar result to that of pseudoginsenoside-RT 1 was obtained. At higher doses of 10 and 30 mg/kg, it produced a transient decrease in MAP with prolonged (over 30 min, Figure 2b ) decrease in heart rate (Figures 1e and  1f ). The other two major components, RT 3 and RT 5 , at doses of 10 and 30 mg/kg, produced no changes in MAP and heart rate in anesthetized rats (data not shown).
Bioguided isolation was undertaken and 11 compounds were isolated from the crude n-butanol extract of the fresh fruits of R. siamensis. Tyramine, pseudoginsenoside-RP 1 , pseudoginsenoside-RT 1 methyl ester, pseudoginsenoside-RT 1 , pseudoginsenoside-RT 3 and pseudoginsenoside-RT 5 were the major components: 0.2-0.7% of the crude nbutanol extract. The other 5 components were present at levels of 0.01-0.02%. Due to limited availability of the pure substances, therefore, only the major constituents were tested for their activities on blood pressure and heart rate in anesthetized rats. As shown in the results section, tyramine caused an increase in MAP and heart rate, whereas pseudoginsenoside-RT 1 and -RP 1 , but not -RT 3 and -RT 5 , caused a decrease in MAP and heart rate. These results suggest that the hypertensive activity of the n-butanol extract of the fresh fruits of R. siamensis would be due to tyramine, whereas pseudoginsenosides-RT 1 and -RP 1 would be responsible for the hypotensive action of the extract.
Experimental
General procedures: UV spectra were measured on a Perkin-Elmer Lambda 20 spectrophotometer (Perkin-Elmer, Boston, MA USA). GC-MS was performed on a TSQ-700 (Finningan MAT, San Jose, CA, USA) using a capillary column SPB-50 (30 m x 0.25 mm id., Supelco). Mass spectra were obtained on a TSQ-700 triple stage quadrupole instrument (Finningan MAT, San Jose, CA, USA). 1 H and 13 C NMR spectra were recorded on a Varian Inova 500 spectrometer (Varian, Palo Alto, CA, USA) (500 MHz and 125 MHz, respectively) in either DMSO-d 6 or CDCl 3 ; chemical shifts in ppm as δ  rel. to Me 4 Si (internal standard). TLC: silica gel 60 F 254 Al sheets (Merck), detection at 254 and 365 nm. Analytical HPLC was carried out on a HP 1100 system equipped with a photodiode array detector (Agilent Technologies, Wilmington, DE, USA). Extracts and fractions were analyzed on a SymmetryShield C 18 column (5 μm, 2.1 x 150 mm; Waters, Bedford, MA, USA). Semipreparative HPLC was carried out with a Shimadzu LC-8A pump (Shimadzu, Kyoto, Japan) equipped with a Knauer UV detector using a μBondapak ® C 18 prepacked column (10 μm, 25 x 100 mm; Waters), flow rate 10 mL/min, detection UV 210 nm.
Chemicals used in the extraction protocol were purchased from Fluka (Buchs, Switzerland). 
Extraction and isolation:
Fresh fruits of Randia siamensis (5 kg) were blended and twice extracted with MeOH-H 2 O (80:20 v/v). After filtration and removal of solvent by evaporation under reduced pressure, a residue was obtained which was dissolved in water. Liquid/liquid partition was undertaken with chloroform, followed by n-butanol. The n-butanol phase was evaporated under reduced pressure, and the residue was lyophilized to yield a crude yellowish powder referred to as the n-butanol extract (126.18 g). Part of this extract (50 g) was subjected to column chromatography over silica gel 100 (850 g) and Fraction B2 (791 mg), was separated using gel filtration on Sephadex G-15 (500 g) and a mixture of MeOH-H 2 O 1:1 (500 mL) as eluent. Ten ml fractions were collected. Fraction C4 afforded compound 1 RS 1 (23 mg) and fraction C5 afforded compound 2 RS 2 (27 mg).
The cardiovascular active fraction A3 (17.56 g), which was also obtained from the silica gel 100 column, was subjected to column chromatography over silica gel 60 (850 g) and eluted with CHCl 3 -MeOH-H 2 O (65:35:5; 4 L and 60:40:8; 1 L) affording 5 fractions (E1-E5). The fraction E2 (2.09 g), which produced a slight decrease in MAP in anesthetized rats, was further fractionated by silica gel reversed phase C 18 column chromatography using gradient elution of MeOH-H 2 O: 50% MeOH (2.5 L), 60% MeOH (6 L) and 70% MeOH (2.8 L). Eight fractions (F1-F8) were obtained; fraction F5 afforded compound 3 (pseudoginsenoside-RP 1 , 535.5 mg). Fraction F6 (194.8 mg) was purified by semipreparative HPLC on RP-18 with isocratic elution (70% MeOH + 0.05% TFA) yielding compound 4 (pseudoginsenoside-RT 1 methyl ester, 26.8 mg). The active fraction E3 (8.89 g), which induced increases in MAP and HR in anesthetized rats, was fractionated on a C 18 reversed-phase silica gel (600 g) column using gradient elution of MeOH-H 2 O: 40% MeOH (1.5 L), 50% MeOH (1.5 L), 60% MeOH (1.5 L), 70%MeOH 2.5 L) and 80% MeOH (1 L). Eight fractions (H1-H8), were obtained. Fraction H5 (2.36 g) was separated by semi-preparative HPLC with MeOH-H 2 O-0.05% TFA on a μBondapak ® C 18 prepacked column (10 μm, 25x100 mm, 35% MeOH, flow rate 10 mL/min, UV 210 nm), yielding compounds 5 (tyramine, 259.1 mg) and 6 (pseudoginsenoside-RT 1 , 945.9 mg).
Fraction A4 (1.12 g), which was obtained from the silica gel 100 column, was separated on a C 18 reversed-phase column using a MeOH-H 2 O gradient: 20% MeOH (6.5 L), 30% MeOH (6 L), 40% MeOH (5 L), 50% MeOH (5.5 L) 60% MeOH (3 L) and 70% MeOH (2 L), yielding 5 fractions (K1-K5). Fractions K2 and K4 gave compounds 7 (270.6 mg) and 8 (299.9 mg), respectively. Fraction K1 (70.2 mg) was separated by semi-preparative HPLC with MeOH-H 2 O-0.05% TFA on a μBondapak ® C 18 pre-packed column (10 μm, 25x100 mm, 10% MeOH, flow rate 10 mL/min, UV 210 nm), yielding compound 9 (5-O-[Z]-caffeoylquinic acid, 32.5 mg). Fractions K3 (120.8 mg) and K5 (215.1 mg) were also purified by semi-preparative HPLC with MeOH-H 2 O-0.05% Sugar hydrolysis: Hydrolysis was performed on compounds 1-4 and 6-11 to determine the nature of the sugar moiety. The reaction was carried out on 2 mg of each product. The compounds were refluxed with a solution of 2N HCl for 4 h. The solution was then neutralized with Na 2 CO 3 and extracted with CH 2 Cl 2 to give an aqueous fraction containing the sugar(s) and a CH 2 Cl 2 fraction containing the aglycone.
Sugar analysis by GC-MS:
GC analysis was performed on the silylated sugars. The silylation reaction was performed using 0.5 mg of the fraction containing the sugar(s). The sugar fraction obtained by hydrolysis was solubilized in a mixture of pyridine (0.2 mL) and BSTFA (N,Obis(trimethylsilyl)-trifluoracetamide) (0.2 mL). The mixture was stirred for 2 h and then the solvents were evaporated by a flow of N 2 at room temperature. The crude reaction mixture was solubilized in 0.5 mL of heptane and 1 μL was analyzed by GC using sugar standards. GC-MS runs were performed using a 30 m x 0.25 mm i.d. SPB-50 (Supleco) column connected to a Finnigan-MAT/TSQ-700 triple stage quadrupole MS instrument, with an initial temperature of 70°C for 1 min and then temperature programming to 300°C at a rate of 10°/min. The retention times (rhamnose 13.7 min, arabinose 14.5 min, xylose 15.9 min, glucose 18.5 min and galactose 19.0 min) and fragmentation patterns of the analytes were compared with those of authentic sugar silylated standards.
